PolyPeptide Group AG (PPGN.SW) Stock Price, News & Chart

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close41.35

Open41.30

Day range41.0541.35

52-week range21.8050.10

Off day high−0.48%

Off 52-week high−17.86%

Volume6.24K

Avg. volume (3M)96.54K

Market cap1.36B

EPS (TTM)0.4100

Forward P/E29.38

P/E ratio (TTM)100.37

Dividend yield—

Beta (5Y)1.04

Shares outstanding33.02M

Short interest—

Earnings dateAug 13, 2026

Analyst target42.46

Profit margin3.15%

Against its peers

Compare in full ›

	PPGN.SW	BIOA	ALPA.NS	PHARMAID.BO	PHN.MI	9989.HK
Market cap	1.36B	273.09M	1.14B	1.03B	697.07M	5.99B
P/E (TTM)	100.4	—	33.7	—	34.0	27.2
Forward P/E	29.4	-2.4	10.3	—	23.3	8.0
Price/book	4.2	0.7	0.6	2.2	10.0	0.4
Dividend yield	—	—	—	—	1.66%	4.12%
1-year change	+78.24%	−20.53%	−40.53%	−40.31%	+59.82%	−26.10%
Today	−0.48%	−0.17%	+0.26%	−0.82%	+0.41%	+1.12%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to PolyPeptide's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
BioAge Labs, Inc.BIOA · Drug Manufacturers - Specialty & Generic	273.09M	5.95	−0.17%
Alpa Laboratories LimitedALPA.NS · Drug Manufacturers - Specialty & Generic	1.14B	54.24	+0.26%
Pharmaids Pharmaceuticals LimitedPHARMAID.BO · Drug Manufacturers - Specialty & Generic	1.03B	29.09	−0.82%
Pharmanutra S.p.A.PHN.MI · Drug Manufacturers - Specialty & Generic	697.07M	72.80	+0.41%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.9989.HK · Drug Manufacturers - Specialty & Generic	5.99B	4.080	+1.12%
Pharma Foods International Co., Ltd.2929.T · Drug Manufacturers - Specialty & Generic	17.14B	590.00	−0.17%
RPG Life Sciences LimitedRPGLIFE.NS · Drug Manufacturers - Specialty & Generic	42.93B	2,595.70	−0.11%
Aprogen Biologics Inc.003060.KS · Drug Manufacturers - Specialty & Generic	21.35B	1,313.00	+0.54%

The stocks whose daily moves over the past year went most closely with PolyPeptide's: the correlation of their daily returns, where 1 would be moving as one.

Company	Mkt cap	Price	Today
Bachem Holding AGBANB.SW · Correlation 0.47	6.19B	82.60	+1.16%

What visitors to PolyPeptide's page also look at.

Company	Mkt cap	Price	Today
BACHEM NBANB.SW	6.19B	82.60	+1.16%
SIEGFRIED NSFZN.SW	3.27B	74.70	−0.33%
COMET NCOTN.SW	2.47B	317.80	−0.19%
YPSOMED HLDGYPSN.SW	5.35B	406.60	+1.19%
TECAN GROUP AG NTECN.SW	3.39B	275.00	+12.43%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All PPGN.SW news ›

@clin_trials·2d agoPositive

Samsung Biologics Secures 97.66% of PolyPeptide Shares in Tender Offer

Samsung Biologics' pending PolyPeptide deal adds peptide API manufacturing, including GLP-1 supply, to its antibody and ADC CDMO services. The deal follows a broader shift toward complex modalities at the company. In an earlier BioPharm…

GeneOnline News -·2d agoPositive

Samsung Biologics Executes 97.99% PolyPeptide Takeover to Claim Peptide Dominance

The global contract development and manufacturing organization landscape is shifting fast. Biopharmaceutical pipelines are moving toward complex synthetic peptides and multi modality therapeutics. In a major milestone for cross border…

Nature·Oct 29Negative

Atomistic islet amyloid polypeptide fibril simulations reveal interplay of amyloid kinetic and mechanical stability

Here, we combine all-atom molecular dynamics simulations of an infinite, periodically repeated fibril, umbrella sampling methods, and non-Markovian reaction rate theory to quantify the stability of IAPP fibrils against fragmentation along…

TradingView·Oct 16

PolyPeptide Group: Definitive interim result of the public tender offer of Samsung Biologics Co., Ltd.

PolyPeptide Group / Key word(s): Tender Offer PolyPeptide Group: Definitive interim result of the public tender offer of Samsung Biologics Co., Ltd. 16-Oct-2026 / 07:00 CET/CEST Media Release – ad hoc announcement pursuant to Art. 53 LR…

Seoul Economic Daily·Oct 13Positive

Samsung Biologics Clears Tender Offer Threshold for PolyPeptide Group

Preliminary Interim Results Show 87.88% Tendered, Above 66.7% Minimum Deal to Close by End-November After Regulatory Approvals, Opening Peptide Push Samsung Biologics (207940.KS) has cleared the minimum acceptance threshold in its tender…

CHOSUNBIZ·Oct 13Positive

Samsung Biologics secures 88% in Polypeptide bid, targets November close

Tender take-up tops threshold as Samsung Biologics eyes peptide CDMO expansion and November finish Samsung Biologics(207940) secured 87.88% of the shares targeted in the tender offer to acquire Swiss peptide contract development and…

From the 4Search news index, newest first.

In the news

7mentions in 30 days

7with it in the headline

Positivesentiment

Most coverage from

tradingview.com3
biopharminternational.com1
biz.chosun.com1
en.sedaily.com1
geneonline.com1

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.